Skip to main content
. Author manuscript; available in PMC: 2019 Apr 12.
Published in final edited form as: Int J Pharm. 2017 Nov 21;538(1-2):48–56. doi: 10.1016/j.ijpharm.2017.11.037

Fig. 2.

Fig. 2.

In vivo performance of 4HPR PLGA millicylinder formulation without solubilizers (10% 4HPR + 3% MgCO3). a) 4HPR release in vivo vs. in vitro (in a solubilizing media containing PBS+ 2%Tween), b) in vivo erosion of 4HPR PLGA implants compared to sham implants (PLGA + 3% MgCO3 only), and c) in vivo water uptake in 4HPR PLGA implants and sham PLGA implants. Values represent mean ± SE (n = 3).